ÜBER DIESEN PODCAST 🔗

Aktualisierungshäufigkeit:
biweekly
Durchschnittliche Audiolänge:
31 minutes
Gastinterviews
Englisch
Vereinigte Staaten
30 Folgen
seit 8. September 2025
episodic

NEUESTE FOLGEN 🔗

In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with Michael Fanous, Founder of SCANIMUS. Michael discusses how SCANIMUS combines continuous slide scanning with AI image reconstruction to make digital pathology more accessible. The conversation explores the …

VERGANGENE FOLGEN SUCHEN

Vorhandene Folgen von Executive Insights for Life Sciences Innovators durchsuchen.

FRÜHERE EPISODEN

In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with Ryan Beal, M.D., Founder and CEO of Dyve Biosciences. Ryan discusses how Dyve is working to translate decades of research on tumor acidity into new therapeutic approaches for cancer. The conversation explo…
In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with Mark Rutledge, President and CEO of World Precision Instruments. Mark discusses how evolving research needs are reshaping the tools and technologies used in preclinical science. The conversation explores t…
In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with Justin Byers, Founder and CEO of Axio BioPharma. Justin discusses why the next generation of AI-enabled biomanufacturing depends on something more fundamental than better algorithms: better access to struc…
In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with Dhruv Patwardhan, Founder of LuminOne. Dhruv discusses how AI can improve commercial decision-making in life sciences by helping teams make better use of fragmented market, account, and customer signals. T…
In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with Pawel Krysiak, President & CEO of Jaya Biosciences. Pawel discusses JayaBio’s work to develop CNS-directed gene therapies for genetically defined neurodegenerative diseases, including Alzheimer’s, Park…
In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with David Pass, CEO and President of AltrixBio. David discusses AltrixBio’s work to advance AJN003, a once-daily, oral, gut-targeted therapeutic candidate being developed for type 2 diabetes, obesity, and rela…
In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with Dave Gallup, Co-Founder and CEO of EMPIRI, an oncology platform company advancing functional precision oncology through its E-slice platform. Dave discusses how EMPIRI is using live human tumor tissue to m…
In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with Dr. Anil Goyal, Co-Founder and CEO of IMMvention Therapeutix, a VC-backed biotechnology company developing globally accessible therapies for rare and chronic diseases, including sickle cell disease and Fri…
In this episode of Executive Insights for Life Sciences Innovators, Don Alexander speaks with Stan Watowich, Founder and CEO of Ridgeline Therapeutics and Professor of Biochemistry and Molecular Biology at the University of Texas Medical Branch. Stan shares his journey from academic science to biot…
Rechtliche Hinweise: Der auf dieser Seite eingebettete Podcast und das Bildmaterial stammen von GeneCoda® Executive Search, das Eigentum seines Eigentümers ist und nicht mit Listen Notes, Inc. verbunden ist oder von diesen unterstützt wird.